Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gynecology · Atypical Polypoid Adenomyoma

Understanding Atypical Polypoid Adenomyoma (APA)

At a Glance

Atypical polypoid adenomyoma (APA) is a rare, noncancerous growth of the uterine lining. It can coexist with endometrial cancer or precancer, so careful tissue assessment, complete removal when appropriate, and long-term biopsy follow-up are important.

An atypical polypoid adenomyoma (APA) is a rare, non-cancerous growth that occurs in the lining of the uterus (endometrium). Because it contains “atypical” cells and shares some characteristics with uterine cancer, receiving this diagnosis can be frightening. However, APA is a distinct condition that is generally considered premalignant-associated—meaning it is not cancer itself, but it has an important association with coexisting or subsequently detected endometrial cancer [1][2].

What This Diagnosis Does and Does Not Mean

  • It is not cancer: APA is a benign-appearing lesion, but a thorough specimen is needed to ensure no precancer or cancer is coexisting in the uterus.
  • The evidence is limited: Because APA is rare, much of what we know comes from small observational studies rather than large clinical trials.

What is APA?

APA is described by doctors as a biphasic lesion, meaning it is made up of two different types of tissue working together [3].

  • Atypical endometrioid glands: These are the “building blocks” of the uterine lining that have begun to grow in complex or unusual patterns [3].
  • Fibromuscular stroma: These glands are embedded in a tough, muscle-like tissue rather than the soft tissue usually found in the uterine lining [3].
  • Squamous morules: These are small, round clusters of cells that often appear within the glands. While they can occur in other lesions, they are a common feature that helps pathologists distinguish APA from other conditions [4][5].

Incidence and Rarity

If you feel like you haven’t heard of APA, it is because it is exceptionally rare. By late 2018, only 466 cases had been documented in medical literature worldwide [6]. Because it is so uncommon, it does not have a standard “incidence rate” (like 1 in 1,000 people). Instead, it is mostly identified in individual case reports or small clinical studies.

It most frequently affects women of childbearing age, though it can sometimes occur after menopause [7]. Because it is rare, your medical team may consult with a gynecologic pathologist—a specialist who focuses on female reproductive tissues—to ensure the diagnosis is accurate [4].

Common Symptoms and Presentation

Most women diagnosed with APA seek medical attention because of changes in their menstrual cycle or difficulties with reproduction. Typical presentations include:

  • Abnormal Uterine Bleeding (AUB): This is the most common symptom, often manifesting as heavy periods (menorrhagia) or bleeding between periods [7][8].
  • Infertility: Some women discover they have APA during a workup for difficulty getting pregnant [9].
  • Incidental Findings: In some cases, there are no symptoms at all, and the lesion is found during a routine imaging or a procedure for an unrelated issue [7].

The growth is often found in the upper part of the uterus (fundus) or the lower uterine segment, as its location can vary from patient to patient, and can range in size from a few millimeters to several centimeters [3][7].

The Link Between APA and Cancer

One of the most important things to understand about APA is its relationship with endometrial cancer. While APA is not cancer, the two can sometimes “overlap” or happen at the same time:

  • Coexistence: In various small retrospective studies, between 5.9% and 10.8% of women with APA were found to have concurrent endometrial cancer at the time of diagnosis [2][7].
  • Progression: If the APA is treated conservatively, there is an uncertain risk it could progress to cancer later. Estimates for this risk vary in research—sometimes reported between 10% and 20%—but these figures come from small series with differing follow-up lengths, and a later cancer might sometimes be an unrecognized concurrent lesion rather than true transformation [10][11].
  • Precursor signals: APA can also coexist with atypical hyperplasia (also called EIN), which is a known precancerous condition of the uterine lining [2].

Because of these risks, the primary goal of treatment is to ensure the lesion is adequately assessed, fully removed if fertility is desired, and closely monitored [2][12].

Why Diagnosis Can Be Challenging

Because APA contains muscle-like tissue, it can sometimes mimic the appearance of myoinvasive carcinoma (cancer that has grown into the uterine wall) [4]. To get the most accurate diagnosis, doctors prefer using hysteroscopy—a procedure where a small camera is inserted into the uterus—to see the lesion and remove it precisely, rather than a “blind” biopsy or D&C, which might miss parts of the growth [13][14]. Special laboratory stains (like p16 or SATB2) are sometimes used as adjuncts by pathologists to help confirm it is an APA rather than a more aggressive cancer [4][5].

Moving Toward Treatment

There is no single “standard” protocol for APA because it is so rare. Treatment is highly individualized based on whether you wish to have children in the future [2].

  • Fertility-Sparing Care: For those who want to conceive, doctors may perform a complete hysteroscopic resection to remove the growth while leaving the uterus intact [13][2].
  • Definitive Care: For those who have completed childbearing, a hysterectomy (removal of the uterus) is often a definitive option that removes the uterine site to prevent the condition from returning or progressing to cancer [2][15].

Regardless of the path you choose, long-term follow-up with regular biopsies is essential to ensure the lining of the uterus remains healthy [16][17].

Common questions in this guide

Is atypical polypoid adenomyoma the same as uterine cancer?
No. Atypical polypoid adenomyoma (APA) is a rare growth in the uterine lining that is not cancer itself, but it can be found alongside precancerous changes or endometrial cancer. A complete tissue assessment is important to look for those conditions.
What symptoms might an APA cause?
The most common presentation is abnormal uterine bleeding, such as unusually heavy periods or bleeding between periods. Some people are evaluated because of difficulty becoming pregnant, while others have no symptoms and the lesion is found incidentally.
How do doctors confirm an atypical polypoid adenomyoma diagnosis?
Doctors often use hysteroscopy, which lets them see the inside of the uterus and remove the lesion precisely for examination. A blind biopsy or dilation and curettage may miss part of the growth, and a gynecologic pathologist may use additional stains to distinguish APA from cancer.
What is the connection between APA and endometrial cancer?
APA is not cancer, but small studies found cancer of the uterine lining at the same time in about 5.9% to 10.8% of patients. Reports of later cancer after fertility-sparing treatment range from about 10% to 20%, but estimates are uncertain and may include cancer that was present but not detected initially.
Can APA be treated while preserving fertility?
Often, doctors can remove the lesion with a complete hysteroscopic resection while leaving the uterus in place. This approach is individualized and requires long-term follow-up with regular biopsies because of APA's association with precancer and cancer.
Why might a doctor recommend hysterectomy for APA?
After childbearing is complete, hysterectomy may be offered as a definitive treatment because it removes the uterus and the site of the lesion. The best option depends on the pathology findings, fertility goals, and discussion with the treating team.
How important is follow-up after APA treatment?
Long-term follow-up with regular biopsies is important, especially after fertility-sparing treatment. It helps check that the uterine lining remains healthy and that no precancer or cancer is developing or was missed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my diagnosis based on a blind biopsy or a hysteroscopic resection?
  2. 2.Did the pathologist find any signs of concurrent atypical hyperplasia or endometrial cancer in my sample?
  3. 3.Given my desire for future fertility, what is the specific plan for monitoring and follow-up biopsies?
  4. 4.How does the presence of 'squamous morules' in my pathology report affect my long-term risk?
  5. 5.What specific surgical technique (such as four-step resection) do you recommend for removing this lesion?
  6. 6.If I plan to conceive, how soon after treatment should I begin trying, and do I need to see a fertility specialist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus.

    McCluggage WG

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016; (29 Suppl 1()):S78-91 doi:10.1038/modpathol.2015.137.

    PMID: 26715175
  2. 2

    Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review.

    Raffone A, Travaglino A, Saccone G, et al.

    Acta obstetricia et gynecologica Scandinavica 2019; (98(7)):842-855 doi:10.1111/aogs.13553.

    PMID: 30714089
  3. 3

    Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.

    Travaglino A, Raffone A, Saccone G, et al.

    Applied immunohistochemistry & molecular morphology : AIMM 2020; (28(8)):646-653 doi:10.1097/PAI.0000000000000780.

    PMID: 31855579
  4. 4

    Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.

    Worrell HI, Sciallis AP, Skala SL

    Histopathology 2021; (79(1)):96-105 doi:10.1111/his.14338.

    PMID: 33459390
  5. 5

    [Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].

    Kommoss F, Lax SF

    Der Pathologe 2016; (37(6)):512-520 doi:10.1007/s00292-016-0236-y.

    PMID: 27681950
  6. 6

    Uncommon Mixed Endometrial-Myometrial Benign Tumors of the Reproductive Tract: Literature Review.

    Habiba M, Brosens I, Zannoni GF, Benagiano G

    Gynecologic and obstetric investigation 2019; (84(6)):521-547 doi:10.1159/000499019.

    PMID: 30889596
  7. 7

    A Clinicopathological Review of 203 Cases of Atypical Polypoid Adenomyoma of the Uterus.

    Sun Y, Tian L, Liu G

    Journal of clinical medicine 2023; (12(4)) doi:10.3390/jcm12041511.

    PMID: 36836047
  8. 8

    [Atypical polypoid adenomyoma of the uterus: a clinicopathological review of 27 cases].

    Bai TJ, Bao DM, Li Y, et al.

    Zhonghua fu chan ke za zhi 2017; (52(4)):244-248 doi:10.3760/cma.j.issn.0529-567X.2017.04.006.

    PMID: 28441840
  9. 9

    Management of atypical polypoid adenomyomas. A case series.

    Grimbizis GF, Mikos T, Miliaras D, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2017; (215()):1-5 doi:10.1016/j.ejogrb.2017.05.017.

    PMID: 28578202
  10. 10

    Clinical presentation and management of atypical polypoid adenomyomas: Systematic review of the literature.

    Mikos T, Tsolakidis D, Grimbizis GF

    European journal of obstetrics, gynecology, and reproductive biology 2019; (236()):14-21 doi:10.1016/j.ejogrb.2019.02.027.

    PMID: 30875539
  11. 11

    Hysteroscopic Transcervical Resection for Atypical Polypoid Adenomyoma of the Uterus: A Valid, Fertility-Preserving Option.

    Chiyoda T, Lin BL, Saotome K, et al.

    Journal of minimally invasive gynecology 2018; (25(1)):163-169.e1 doi:10.1016/j.jmig.2017.08.659.

    PMID: 29038039
  12. 12

    Clinical analysis of 44 cases of atypical polypoid adenomyoma of the uterus.

    Wang X, Guo Y

    BMC women's health 2022; (22(1)):60 doi:10.1186/s12905-022-01643-y.

    PMID: 35246106
  13. 13

    Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis.

    Biasioli A, Londero AP, Orsaria M, et al.

    Medicine 2020; (99(26)):e20491 doi:10.1097/MD.0000000000020491.

    PMID: 32590732
  14. 14

    MRI and Transvaginal Ultrasound Findings of Atypical Polypoid Adenomyoma: A Case Report.

    Tan Y, Hu X, Song X, Zhang WJ

    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2022; (37(1)):82-86 doi:10.24920/003911.

    PMID: 35256047
  15. 15

    Clinicopathological Characteristics of Atypical Polypoid Adenomyoma of the Uterus in Association With Endometrial Atypical Hyperplasia and Endometrioid Carcinoma.

    Kim T, Cho YA, Kim HS

    In vivo (Athens, Greece) 2025; (39(6)):3539-3551 doi:10.21873/invivo.14152.

    PMID: 41167709
  16. 16

    Oncologic outcomes of conservative treatment of atypical polypoid adenomyoma of the uterus: A two-center experience.

    Casadio P, Raffone A, Travaglino A, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2022; (159(1)):79-85 doi:10.1002/ijgo.14077.

    PMID: 34921691
  17. 17

    Clinicopathological characteristics and fertility preserving treatment of atypical polypoid adenomyoma.

    Wang Q, Shan W, Yang B, et al.

    Frontiers in oncology 2024; (14()):1386931 doi:10.3389/fonc.2024.1386931.

    PMID: 38863630

This page is for informational purposes only and does not constitute medical advice about atypical polypoid adenomyoma. Your gynecologist and gynecologic pathologist can interpret your tissue results and discuss fertility, treatment, and follow-up options.

Get notified when new evidence is published on uterine corpus atypical polypoid adenomyoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.